Partnerships for Ebola: Pharma industry’s $351M push to stop the outbreak

Billed as the world’s biggest public-private partnership in the life sciences, a multibillion-euro fund called the Innovative Medicines Initiative aims to mobilize additional stakeholders and funding to help in the complex fight against Ebola.

About the author

  • Bill Hinchberger

    Bill Hinchberger is a global communications professional and educator. He studied at Berkeley and has taught at the Sorbonne. Based mostly in Paris, he spends quality time in Brazil and the United States, and works extensively in Africa and Latin America. He has served as an international correspondent for The Financial Times, Business Week, ARTnews, Variety, and others. One current focus of his work is content creation for foundations, NGOs and other organizations, especially those working on issues related to international affairs, the environment and development. He also runs training programs for professional journalists, notably in Africa, and is an associate of Rain Barrel Communications, a leading consultancy for social justice projects.

Join the Discussion